Research study Program year 2024 Source: CMS Open Payments

P3 2L NSCLC Mono Comparator

Research payments

$3,239,329

104 payments

Through program year 2024, $3,239,329 in research payments was reported against P3 2L NSCLC Mono Comparator, across 104 payments, paid by Amgen Inc..

Paid by
Amgen Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2024 Research $890,322 20
2023 Research $1,759,150 25
2022 Research $589,857 59

Breakdown

Who paid Research payments · program years 2022–2024
  1. Amgen Inc. $3,239,329 104 payments
Who received the money Research payments · program years 2022–2024
  1. Rocky Mountain Cancer Centers Organisation paid for research $582,633 6 payments
  2. Florida Cancer Specialists - Fort Myers Organisation paid for research $483,628 6 payments
  3. Sarah Cannon Research Institution Llc Organisation paid for research $459,211 5 payments
  4. Investigational Pharmacy Services Organisation paid for research $397,440 1 payment
  5. US Onc Research LLC Organisation paid for research $329,870 9 payments
  6. Ut Md Anderson Cancer Center Teaching hospital · TX $267,147 5 payments
  7. Wake Forest Baptist, Dept Of Pharm Organisation paid for research $158,976 1 payment
  8. City Of Hope National Medical Ctr Teaching hospital · CA $103,634 3 payments
  9. Oncology Hematology Care INC Organisation paid for research $101,040 4 payments
  10. Oncology Hematology Care Incorporated Organisation paid for research $87,834 2 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record